Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRevel Collect Regulatory News (RBG)

  • There is currently no data for RBG

Rule 8.3- Rensburg Sheppards

12 Apr 2010 14:52

RNS Number : 0475K
Lloyds Banking Group PLC
12 April 2010
 

FORM 8.3

 

DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE

(Rule 8.3 of the Takeover Code)

 

1. KEY INFORMATION

 

Name of person dealing (Note 1)

Lloyds Banking Group plc and its subsidiaries

Company dealt in

Rensburg Sheppards

Class of relevant security to which the dealings being disclosed relate (Note 2)

Ordinary 10.989p

Date of dealing

09 April 2010

 

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

Long

 

Short

 

Number

(%)

Number

(%)

(1) Relevant securities

364,812

(0.831%)

 

 

(2) Derivatives (other than options)

 

 

 

 

(3) Options and agreements to purchase/sell

 

 

 

 

Total

364,812

(0.831%)

 

 

 

 

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

 

Class of relevant security:

Long

 

Short

 

Number

(%)

Number

(%)

(1) Relevant securities

 

 

 

 

(2) Derivatives (other than options)

 

 

 

 

(3) Options and agreements to purchase/sell

 

 

 

 

Total

 

 

 

 

 

(c) Rights to subscribe (Note 3)

 

Class of relevant security:

Details

 

 

 

3. DEALINGS (Note 4)

 

(a) Purchases and sales

 

Purchase/sale

Number of securities

Price per unit (Note 5)

Sale

129,688

£8.715

 

 

 

 

 

 

(b) Derivatives transactions (other than options)

 

Product name, e.g. CFD

 

Long/short (Note 6)

Number of securities (Note 7)

Price per unit (Note 5)

 

 

 

 

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

 

Product name,e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

(ii) Exercising

 

Product name, e.g. call option

Number of securities

Exercise price per unit (Note 5) 

 

 

 

 

(d) Other dealings (including new securities) (Note 4)

 

Nature of transaction (Note 8)

Details

Price per unit (if applicable) (Note 5)

 

 

 

 

4. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

……………………………………………………………………

N/A

……………………………………………………………………

Is a Supplemental Form 8 attached? (Note 9) NO

 

 

Date of disclosure

12 April 2010

Contact name

Matthew Wilson

Telephone number

0113 235 7729

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection (Note 10)

 

Notes

The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETGGUUACUPUGWP
Date   Source Headline
22nd Jun 20218:50 amRNSDirector/PDMR Shareholding
18th Jun 20218:06 amRNSHolding(s) in Company
15th Jun 20214:23 pmRNSDirector/PDMR Shareholding
15th Jun 20218:27 amRNSSchedule 2(g) Update
14th Jun 20212:31 pmRNSResult of GM, Director/PDMR, Total Voting Rights
14th Jun 20217:00 amRNSResult of Open Offer
27th May 20216:11 pmRNSPublication and Despatch of Circular
26th May 20217:00 amRNSResults of the Firm Placing and Placing
25th May 20214:44 pmRNSFirm Placing and Placing and Open Offer
19th May 20211:04 pmRNSHolding(s) in Company
11th May 20217:00 amRNSRe-opening Update
13th Apr 20217:00 amRNSInterim Results
4th Mar 20217:00 amRNSCOVID-19 Update/Notification Interim Results Date
15th Feb 202112:01 pmRNSResult of General Meeting
22nd Jan 20211:07 pmRNSNotice of GM
4th Jan 20214:41 pmRNSSecond Price Monitoring Extn
4th Jan 20214:35 pmRNSPrice Monitoring Extension
24th Dec 202011:36 amRNSGrant of Options
22nd Dec 202012:30 pmRNSResult of AGM
21st Dec 20209:05 amRNSSecond Price Monitoring Extn
21st Dec 20209:00 amRNSPrice Monitoring Extension
17th Dec 20207:00 amRNSPreliminary Results
10th Dec 20204:41 pmRNSSecond Price Monitoring Extn
10th Dec 20204:36 pmRNSPrice Monitoring Extension
27th Nov 20203:40 pmRNSNotice of 2020 Annual General Meeting
17th Nov 202011:40 amRNSHolding(s) in Company
16th Nov 20202:06 pmRNSSecond Price Monitoring Extn
16th Nov 20202:00 pmRNSPrice Monitoring Extension
13th Nov 20202:37 pmRNSCVA successfully approved
9th Nov 20204:41 pmRNSSecond Price Monitoring Extn
9th Nov 20204:37 pmRNSPrice Monitoring Extension
9th Nov 20202:06 pmRNSSecond Price Monitoring Extn
9th Nov 20202:00 pmRNSPrice Monitoring Extension
28th Oct 20205:12 pmRNSHolding(s) in Company
28th Oct 20208:48 amRNSHolding(s) in Company
28th Oct 20208:41 amRNSHolding(s) in Company
27th Oct 20207:00 amRNSLaunch of CVA in subsidiary entity
12th Oct 202012:16 pmRNSHolding(s) in Company
6th Oct 20204:40 pmRNSHolding(s) in Company
1st Oct 20203:36 pmRNSHolding(s) in Company
28th Sep 202012:59 pmRNSHolding(s) in Company
25th Sep 20202:05 pmRNSSecond Price Monitoring Extn
25th Sep 20202:01 pmRNSPrice Monitoring Extension
25th Sep 202011:26 amRNSStatement re press speculation
18th Sep 20201:25 pmRNSHolding(s) in Company
9th Sep 20205:02 pmRNSHolding(s) in Company
8th Sep 202010:15 amRNSHolding(s) in Company
3rd Sep 20207:00 amRNSTrading Update and FY results reporting date
21st Aug 202010:58 amRNSHolding(s) in Company
31st Jul 20202:35 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.